Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1971 Jun 26;2(5764):739–741. doi: 10.1136/bmj.2.5764.739

Potassium-sparing Agents during Diuretic Therapy in Hypertension

T J McKenna, J F Donohoe, T G Brien, J J Healy, B St J Canning, F P Muldowney
PMCID: PMC1796357  PMID: 5090761

Abstract

Three pharmacological agents in use as “potassium-sparing” drugs have been tested by serial measurements of total exchangeable potassium (KE) during 4 to 12 weeks of oral diuretic therapy in hypertensive subjects. Triamterene seemed ineffective in the dosage used (50 mg twice daily). Spironolactone (25 mg twice daily) reduced K loss to a considerable extent, while Slow-K (32 mEq daily) completely reversed previous KE deficits. Plasma K levels were a poor indication of degree of KE restoration.

Full text

PDF
739

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. EDMONDS C. J., WILSON G. M. The action of hydroflumethiazide in relation to adrenal steroids and potassium loss. Lancet. 1960 Mar 5;1(7123):505–509. doi: 10.1016/s0140-6736(60)90447-5. [DOI] [PubMed] [Google Scholar]
  2. GIFFORD R. W., Jr, MATTOX V. R., ORVIS A. L., SONES D. A., ROSEVEAR J. W. Effect of thiazide diuretics on plasma volume, body electrolytes, and excretion of aldosterone in hypertension. Circulation. 1961 Nov;24:1197–1205. doi: 10.1161/01.cir.24.5.1197. [DOI] [PubMed] [Google Scholar]
  3. GRIEBLE H. G., JOHNSTON L. C. Treatment of arterial hypertensive disease with diuretics. I. Effects on blood pressure of bendroflumethiazide, potassium chloride, and spironolactone. Arch Intern Med. 1962 Jul;110:26–33. doi: 10.1001/archinte.1962.03620190028004. [DOI] [PubMed] [Google Scholar]
  4. GULYASSY P. F., VAN YPERSELE DE STRIHOU C., SCHWARTZ W. B. On the mechanism of nitrate-induced alkalosis. The possible role of selective chloride depletion in acid-base regulation. J Clin Invest. 1962 Oct;41:1850–1862. doi: 10.1172/JCI104642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HOLLANDER W. ALDOSTERONE ANTAGONISTS IN ARTERIAL HYPERTENSION. Heart Bull. 1963 Nov-Dec;12:108–111. [PubMed] [Google Scholar]
  6. LAWRASON F. D., ALPERT E., MOHR F. L., MCMAHON F. G. ULCERATIVE-OBSTRUCTIVE LESIONS OF THE SMALL INTESTINE. JAMA. 1965 Feb 22;191:641–644. doi: 10.1001/jama.1965.03080080031007. [DOI] [PubMed] [Google Scholar]
  7. LINDHOLMER B., NYMAN E., RAEF L. NONSPECIFIC STENOSING ULCERATION OF THE SMALL BOWEL: A PRELIMINARY REPORT. Acta Chir Scand. 1964 Sep;128:310–311. [PubMed] [Google Scholar]
  8. MORGENSTERN L., FREILICH M., PANISH J. F. THE CIRCUMFERENTIAL SMALL-BOWEL ULCER: CLINICAL ASPECTS IN 17 PATIENTS. JAMA. 1965 Feb 22;191:637–640. doi: 10.1001/jama.1965.03080080027006. [DOI] [PubMed] [Google Scholar]
  9. Myers R. N., Brown C. E., Deaver J. M. In vivo effect of potassium on small bowel. Ann Surg. 1967 Oct;166(4):693–703. doi: 10.1097/00000658-196710000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. PATE M. The world's children and tomorrow. Fed Proc. 1961 Mar;20(Suppl 7):409–410. [PubMed] [Google Scholar]
  11. TALSO P. J., GLYNN M. F., OESTER Y. T., FUDEMA J. BODY COMPOSITION IN HYPOKALEMIC FAMILIAL PERIODIC PARALYSIS. Ann N Y Acad Sci. 1963 Sep 26;110:993–1008. doi: 10.1111/j.1749-6632.1963.tb15816.x. [DOI] [PubMed] [Google Scholar]
  12. WENER J., SCHUCHER R., FRIEDMAN R. TREATMENT OF CONGESTIVE HEART FAILURE WITH TRIAMTERENE. Can Med Assoc J. 1965 Feb 27;92:452–460. [PMC free article] [PubMed] [Google Scholar]
  13. WOLFF F. W., PARMLEY W. W. FURTHER OBSERVATIONS CONCERNING THE HYPERGLYCEMIC ACTIVITY OF BENZOTHIADIAZINES. Diabetes. 1964 Mar-Apr;13:115–121. doi: 10.2337/diab.13.2.115. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES